|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
eFFECTOR Therapeutics, Inc.
| | | Phone: | (858) 925-8215 | Year Established: | 2013 | Main Contact: | Steve Worland, Ph.D., President & CEO | | Other Contacts: | Annette Matthies, Ph.D., VP, Corporate Development Jeremy Barton, M.D., CMO Kevin Webster, Ph.D., Senior VP, Cancer Biology Alana McNulty, M.B.A., CFO Debra Thoma Vallner, Ph.D., MBA, VP, Development Operations Siegfried Reich, Ph.D., Senior VP, Research
| | Company Description | eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. | |
|
|
|
|
|